Drug Type Synthetic peptide vaccine, Prophylactic vaccine |
Synonyms- |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
ALK positive Non-Small Cell Lung Cancer | Phase 2 | United States | 13 May 2024 | |
metastatic non-small cell lung cancer | Phase 2 | United States | 13 May 2024 |